You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Deferasirox

Showing 51 - 75 of 114
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thalassemia Major Trial (Taurine, Placebo)

Not yet recruiting
  • Thalassemia Major
  • Taurine
  • Placebo
  • (no location specified)
Feb 28, 2020

Transfusional Iron Overload, ß-thalassemia Major, Pediatric Rare Anemia Trial in France, Italy (Deferasirox)

Completed
Has Results
  • Transfusional Iron Overload
  • +2 more
  • Deferasirox
  • Lyon, France
  • +3 more
Feb 12, 2017

MDS, Beta-Thalassemia Trial in Hungary (deferasirox)

Completed
  • Myelodysplastic Syndromes
  • Beta-Thalassemia
  • deferasirox
  • Budapest, Hungary
  • +3 more
Feb 22, 2017

High Risk MDS Trial in United States (Azacitidine, Azacitidine plus Deferasirox)

Terminated
Has Results
  • High Risk MDS
  • Little Rock, Arkansas
  • +5 more
Mar 6, 2017

Beta-Thalassemia, Hemosiderosis Trial in Worldwide (deferasirox)

Completed
  • Beta-Thalassemia
  • Hemosiderosis
  • deferasirox
  • Cairo, Egypt
  • +4 more
Feb 28, 2017

Hemochromatosis, MDS Trial in Bergen (Deferasirox, Venesection)

Terminated
  • Hemochromatosis
  • Myelodysplastic Syndromes
  • Deferasirox
  • Venesection
  • Bergen, Norway
    Haukeland University Hospital, Clinical Trial Unit
Jan 20, 2017

Chronic Iron Overload Due to Transfusion-dependant Anemias Trial in Worldwide (Deferasirox dispersible tablet, Defearisox

Completed
Has Results
  • Chronic Iron Overload Due to Transfusion-dependant Anemias
  • Deferasirox dispersible tablet
  • Defearisox film-coated tablet
  • Orange, California
  • +50 more
Jul 22, 2017

Beta Thalassemia Transfusion Dependent Trial in Cagliari, Orbassano (Deferasirox)

Completed
  • Beta Thalassemia Transfusion Dependent
  • Deferasirox
  • Cagliari, Italy
  • +1 more
Dec 8, 2016

Myelodysplastic Syndrome With Low-grade Lesions, Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Tel Hashomer

Completed
  • Myelodysplastic Syndrome With Low-grade Lesions
  • Iron Overload Due to Repeated Red Blood Cell Transfusions
  • Tel Hashomer, Israel
    Chim Sheba Medical Center
Oct 30, 2018

AL-Hijama in Thalassmia Major Trial in Tanta (Al-hijamah, Deferasirox)

Unknown status
  • AL-Hijama in Thalassmia Major
  • Al-hijamah
  • Deferasirox
  • Tanta, Gharbia, Egypt
  • +1 more
Apr 24, 2017

Myelodysplastic Syndrome, Transfusional Iron Overload Trial in Worldwide (Deferasirox)

Terminated
Has Results
  • Myelodysplastic Syndrome
  • Transfusional Iron Overload
  • Deferasirox
  • Caen, Cedex, France
  • +9 more
Mar 1, 2017

Myelodysplastic Syndrome, Thalassemia Trial in Moscow, Saint-Petersburg, St. Petersburg (Deferasirox)

Completed
  • Myelodysplastic Syndrome
  • Thalassemia
  • Deferasirox
  • Moscow, Russian Federation
  • +2 more
Dec 8, 2016

Hemoglobinopathies, MDS, Other Inherited or Acquired Anaemia Trial in Australia (deferasirox)

Completed
  • Hemoglobinopathies
  • +6 more
  • deferasirox
  • Adelaide, Australia
  • +3 more
Feb 20, 2017

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome

Unknown status
  • Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Pierre-Bénite, France
    Centre Hospitalier Lyon Sud
Sep 3, 2018

Iron Overload Trial in Leipzig (Deferasirox)

Completed
  • Iron Overload
  • Deferasirox
  • Leipzig, Germany
    Novartis Investigative Site
Nov 16, 2016

Anemia, Sickle Cell, Transfusion Hemosiderosis Trial in Los Angeles (deferasirox)

Terminated
Has Results
  • Anemia, Sickle Cell
  • Transfusion Hemosiderosis
  • deferasirox
  • Los Angeles, California
    Childrens Hospital Los Angeles
Dec 15, 2016

Iron Mediated Vascular Disease in Sickle Cell Anemia Patients

Completed
  • Sickle Cell Disease
    • Los Angeles, California
      Children's Hospital Los Angeles
    Jan 9, 2019

    MDS, Hemosiderosis Trial in Italy (Deferasirox)

    Completed
    • Myelodysplastic Syndromes
    • Hemosiderosis
    • Deferasirox
    • Alessandria, Italy
    • +16 more
    Nov 21, 2016

    Beta Thalassemia Major Anemia Trial in Cairo. (Metformin)

    Unknown status
    • Beta Thalassemia Major Anemia
    • Cairo., Egypt
    • +1 more
    Jul 16, 2018

    Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major Trial in Turkey

    Completed
    Has Results
    • Iron Overload After Hematopoietic Stem Cell Transplantation (HSCT) in Patients With Beta-thalassemia Major
    • Ankara, Turkey
    • +5 more
    Sep 12, 2016

    Beta-Thalassemia, Iron Overload Trial in Toronto (Amlodipine, Deferasirox)

    Unknown status
    • Beta-Thalassemia
    • Iron Overload
    • Toronto, Ontario, Canada
      University Health Network
    Oct 24, 2016

    Anemia, Sickle Cell Trial in United States (ICL670, deferoxamine)

    Completed
    • Anemia, Sickle Cell
    • ICL670, deferoxamine
    • Mobile, Alabama
    • +33 more
    Aug 18, 2017

    Descriptive Epidemiology on Management of Mucormycosis

    Completed
    • Mycoses
      • New Delhi, Delhi, India
      • +12 more
      Feb 8, 2018

      Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial (Cytarabine, Deferasirox)

      Unknown status
      • Acute Myeloid Leukemia
      • Acute Lymphoid Leukemia
      • (no location specified)
      Feb 24, 2016

      Thalassemia Trial in Karachi (Standard Chelation, Amlodipine)

      Completed
      • Thalassemia
      • Karachi, Sindh, Pakistan
        Aga Khan University Hospital
      Jun 28, 2017